What we are working on

We aim to provide the most meaningful outcomes for patients with ulcerative colitis and Crohn’s disease. Learn about the current initiatives in IBD care.

Our medical innovations treat cardiovascular and metabolism diseases such as heart attacks and diabetes.

Learn more about this complex and challenging area of medicine, and how Roche is redefining treatment for people with diseases of the blood.

Haemophilia A is an inherited bleeding disorder where a person’s blood does not clot properly, leading in severe cases to uncontrolled bleeding, either spontaneously or after minor trauma.

We're advancing our expertise in Immunology and discovering and developing innovative medicines for patients living with severe respiratory and autoimmune diseases.

Viral and bacterial infections are among the leading causes of disability and death. Roche research is committed to finding effective treatments for life-threatening infectious diseases.

With one of the strongest pipelines in the industry, Roche Neuroscience is developing medicines for a range of serious neurological diseases, including multiple sclerosis, Alzheimer’s disease, autism, spinal muscular atrophy, depression, Parkinson’s disease, Down syndrome.

Our scientists take a rigorous, comprehensive approach to understanding cancer biology and drug discovery.

We are focused on saving people’s eyesight from the leading causes of vision loss through pioneering therapies.

Roche Respiratory research focuses on severe respiratory diseases.

Working in both Pharmaceuticals and Diagnostics, we are uniquely positioned to fit the treatment to the patients.

We assess emerging technologies and quickly adopt the ones that can enhance our research efforts in finding new drugs and better diagnostic tests.